Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    January 2018
  1. LABGAA I, Slankamenac K, Schadde E, Jibara G, et al
    Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Am J Surg. 2018;215:125-130.
    PubMed     Text format     Abstract available


  2. RHEE D, Pockaj B, Wasif N, Stucky CC, et al
    Operative outcomes of conventional specimen radiography versus in-operating room specimen radiography in radioactive seed-localized segmental mastectomies.
    Am J Surg. 2018;215:151-154.
    PubMed     Text format     Abstract available


    December 2017
  3. HEELAN GLADDEN AA, Sams S, Gleisner A, Finlayson C, et al
    Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines.
    Am J Surg. 2017;214:1104-1109.
    PubMed     Text format     Abstract available


  4. VELAZCO CS, Wasif N, Pockaj BA, Gray RJ, et al
    Radioactive seed localization for breast conservation surgery: Low positive margin rate with no learning curve.
    Am J Surg. 2017;214:1091-1093.
    PubMed     Text format     Abstract available


  5. CHANG JM, Kosiorek HE, Wasif N, Gray RJ, et al
    The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review.
    Am J Surg. 2017;214:1096-1101.
    PubMed     Text format     Abstract available


    November 2017
  6. TSUNG K, Grobmyer SR, Tu C, Abraham J, et al
    Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Am J Surg. 2017 Nov 14. pii: S0002-9610(17)30998.
    PubMed     Text format     Abstract available


  7. QU LT, Peters S, Cobb AN, Godellas CV, et al
    Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment.
    Am J Surg. 2017 Nov 13. pii: S0002-9610(17)31018.
    PubMed     Text format     Abstract available


    October 2017
  8. ABBOTT AM, Valente SA, Loftus L, Tendulkar RD, et al
    A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
    Am J Surg. 2017;214:629-633.
    PubMed     Text format     Abstract available


  9. BUCKLEY EJ, Zahnd WE, Rea DJ, Mellinger JD, et al
    Impact of rural-urban status on survival after mastectomy without reconstruction versus mastectomy with reconstruction.
    Am J Surg. 2017;214:645-650.
    PubMed     Text format     Abstract available


  10. NURUDEEN S, Guo H, Chun Y, Coopey S, et al
    Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.
    Am J Surg. 2017;214:687-694.
    PubMed     Text format     Abstract available


    September 2017
  11. CHAGPAR A
    Discussion of Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 30. pii: S0002-9610(17)31379.
    PubMed     Text format    


  12. CHAGPAR AB
    On baseball and breast cancer.
    Am J Surg. 2017 Sep 20. pii: S0002-9610(17)31086.
    PubMed     Text format     Abstract available


  13. CHAGPAR AB, Horowitz N, Sanft T, Wilson LD, et al
    Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 19. pii: S0002-9610(17)30420.
    PubMed     Text format     Abstract available


    July 2017
  14. CHIU AS, Thomas P, Killelea BK, Horowitz N, et al
    Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB).
    Am J Surg. 2017 Jul 18. pii: S0002-9610(16)30870.
    PubMed     Text format     Abstract available


  15. CANDELARIA RP, Hansakul P, Thompson AM, Le-Petross H, et al
    Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?
    Am J Surg. 2017 Jul 1. pii: S0002-9610(17)30237.
    PubMed     Text format     Abstract available


    June 2017
  16. FAYANJU OM, Hall CS, Bauldry JB, Karhade M, et al
    Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer.
    Am J Surg. 2017 Jun 23. pii: S0002-9610(17)30118.
    PubMed     Text format     Abstract available


  17. KOZICK Z, Hashmi A, Dove J, Hunsinger M, et al
    Disparities in compliance with the Oncotype DX breast cancer test in the United States: A National Cancer Data Base assessment.
    Am J Surg. 2017 Jun 9. pii: S0002-9610(17)30570.
    PubMed     Text format     Abstract available


  18. EL HAGE CHEHADE H, Wazir U, Mokbel K, Kasem A, et al
    Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.
    Am J Surg. 2017 Jun 3. pii: S0002-9610(17)30531.
    PubMed     Text format     Abstract available


    April 2017
  19. MAYS S, Alabdulkareem H, Christos P, Simmons R, et al
    Surgical outcomes in women >/=70 years undergoing mastectomy with and without reconstruction for breast cancer.
    Am J Surg. 2017 Apr 5. pii: S0002-9610(16)30981.
    PubMed     Text format     Abstract available


  20. COBLE J, Reid V
    Achieving clear margins. Directed shaving using MarginProbe, as compared to a full cavity shave approach.
    Am J Surg. 2017;213:627-630.
    PubMed     Text format     Abstract available


    January 2017
  21. BICHOO RA, Jha CK, Mishra A
    Letter to editor in response to the article entitled "Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and No
    Am J Surg. 2017 Jan 11. pii: S0002-9610(16)30693.
    PubMed     Text format    


  22. JHA CK, Bichoo RA, Johri G, Yadav SK, et al
    Letter to editor in response to article entitled "The clinical implication of the number of lymph nodes harvested during sentinel lymph node biopsy and its effects on survival outcome in patients with node-negative breast cancer".
    Am J Surg. 2017 Jan 1. pii: S0002-9610(16)31098.
    PubMed     Text format    


  23. LALLEMAND M, Barron M, Bingham J, Mosier A, et al
    The true impact of breast magnetic resonance imaging on the management of in situ disease: more is not better.
    Am J Surg. 2017;213:127-131.
    PubMed     Text format     Abstract available


    December 2016
  24. ACOTT AA, Mancino AT
    Flat epithelial atypia on core needle biopsy, must we surgically excise?
    Am J Surg. 2016;212:1211-1213.
    PubMed     Text format     Abstract available


  25. WARD EP, Wang J, Mendez N, Yang J, et al
    Utilization of iron (III)-doped nanoshells for in vivo marking of nonpalpable tumors using a VX2 rabbit model.
    Am J Surg. 2016;212:1140-1146.
    PubMed     Text format     Abstract available


    November 2016
  26. KIM MK, Park HS, Kim JY, Kim S, et al
    The clinical implication of the number of lymph nodes harvested during sentinel lymph node biopsy and its effects on survival outcome in patients with node-negative breast cancer.
    Am J Surg. 2016 Nov 30. pii: S0002-9610(16)30954.
    PubMed     Text format     Abstract available


  27. HENRY LR, Morris LL, Downs R, Schwarz RE, et al
    The impact of immediate breast reconstruction after mastectomy on time to first adjuvant treatment in women with breast cancer in a community setting.
    Am J Surg. 2016 Nov 8. pii: S0002-9610(16)30818.
    PubMed     Text format     Abstract available


    October 2016
  28. FUNG F, Cornacchi SD, Reedijk M, Hodgson N, et al
    Breast cancer recurrence following radioguided seed localization and standard wire localization of nonpalpable invasive and in situ breast cancers: 5-Year follow-up from a randomized controlled trial.
    Am J Surg. 2016 Oct 20. pii: S0002-9610(16)30368.
    PubMed     Text format     Abstract available


  29. SCOTT-CONNER CE, Sugg SL, Lizarraga I
    Invited commentary on "outcomes and feasibility of nipple-sparing mastectomy for node-positive breast cancer patients" by Murphy et al.
    Am J Surg. 2016 Oct 20. pii: S0002-9610(16)30615.
    PubMed     Text format    


  30. ZAMMAR SG, Pockaj BA, Stucky CC, Wasif N, et al
    Is forgoing chemical venous thromboembolism prophylaxis for women undergoing breast-conserving surgery for breast cancer safe?
    Am J Surg. 2016 Oct 3. pii: S0002-9610(16)30626.
    PubMed     Text format     Abstract available


  31. LUDWIG KK, Neuner J, Butler A, Geurts JL, et al
    Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
    Am J Surg. 2016;212:660-669.
    PubMed     Text format     Abstract available


  32. PETTKE E, Ilonzo N, Ayewah M, Tsantes S, et al
    Short-term, postoperative breast cancer outcomes in patients with advanced age.
    Am J Surg. 2016;212:677-681.
    PubMed     Text format     Abstract available


    September 2016
  33. HAYES LM, Frebault JS, Landercasper J, Borgert AJ, et al
    Extramammary findings in diagnostic breast magnetic resonance imaging among patients with known breast cancer: incidence and cost analysis.
    Am J Surg. 2016 Sep 30. pii: S0002-9610(16)30573.
    PubMed     Text format     Abstract available


  34. CHANG JM, Kosiorek HE, Dueck AC, Casey WJ, et al
    Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center.
    Am J Surg. 2016 Sep 29. pii: S0002-9610(16)30566.
    PubMed     Text format     Abstract available


  35. HAFERTEPEN L, Pastorino A, Morman N, Snow J, et al
    Barriers to genetic testing in newly diagnosed breast cancer patients: do surgeons limit testing?
    Am J Surg. 2016 Sep 9. pii: S0002-9610(16)30509.
    PubMed     Text format     Abstract available


  36. MURPHY BL, Hoskin TL, Boughey JC, Degnim AC, et al
    Outcomes and feasibility of nipple-sparing mastectomy for node-positive breast cancer patients.
    Am J Surg. 2016 Sep 3. pii: S0002-9610(16)30505.
    PubMed     Text format     Abstract available


  37. THOMAS A, Weigel RJ, Lynch CF, Spanheimer PM, et al
    Incidence, characteristics, and management of recently diagnosed, microscopically invasive breast cancer by receptor status: Iowa SEER 2000 to 2013.
    Am J Surg. 2016 Sep 2. pii: S0002-9610(16)30504.
    PubMed     Text format     Abstract available


    August 2016
  38. EL HAGE CHEHADE H, Headon H, El Tokhy O, Heeney J, et al
    Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.
    Am J Surg. 2016 Aug 16. pii: S0002-9610(16)30433.
    PubMed     Text format     Abstract available


    July 2016
  39. KILLELEA BK, Chagpar AB, Horowitz NR, Lannin DR, et al
    Characteristics and treatment of human epidermal growth factor receptor 2 positive breast cancer: 43,485 cases from the National Cancer Database treated in 2010 and 2011.
    Am J Surg. 2016 Jul 21. pii: S0002-9610(16)30361.
    PubMed     Text format     Abstract available


    June 2016
  40. FUNG F, Cornacchi SD, Vanniyasingam T, Dao D, et al
    Predictors of 5-year local, regional, and distant recurrent events in a population-based cohort of breast cancer patients.
    Am J Surg. 2016 Jun 14. pii: S0002-9610(16)30290.
    PubMed     Text format     Abstract available


  41. OZANNE EM, Weiss JE, Onega T, DeMartini W, et al
    Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging.
    Am J Surg. 2016 Jun 12. pii: S0002-9610(16)30286.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: